Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 12 - 20 crawled time : 14:30 save search
Neuronetics Announces 510(k) Clearance of MT Cap Technology for NeuroStar® Advanced Therapy for Mental HealthTechnology will save practitioners and patients time during motor threshold determination
Published: 2021-12-20 (Crawled : 14:30) - biospace.com/
STIM | $3.8 -0.78% -0.79% 49K
|
Health Technology
|
| O: 2.4%
H: 2.11%
C: -1.17%
neurostar health clearance save technology star therapy
Intercept Pharmaceuticals Provides Update on Phase 3 REVERSE Trial in Compensated Cirrhosis Due to NASHStudy remains ongoing; top-line data anticipated in Q1 2022 versus near the end of the year
Published: 2021-12-20 (Crawled : 14:30) - biospace.com/
ICPT | $19.0 -0.05% 4M
|
Health Technology
|
| O: -4.49%
H: 4.4%
C: 1.83%
ema als ongoing cirrhosis trial phase 3 nash topline
ImmunityBio Announces Completion of $470 Million Post-merger Financing to Fund Late-stage Cancer Clinical Trials, Phase 3 of COVID T-Cell Universal Boost Vaccine Trial and Provides Update on Bladder Cancer BLA Filing
Published: 2021-12-20 (Crawled : 14:30) - biospace.com/
IBRX | $5.265 7.23% 6.74% 4.6M
|
Manufacturing
|
| O: 1.53%
H: 1.2%
C: -2.41%
AMRS | $0.05 -21.88% -16.36% 47M
|
Process Industries
|
| O: -2.79%
H: 1.93%
C: -3.72%
als bladder cancer trials trial covid cel clinical trials cancer vaccine phase 3 merge t-cell bladder
EDWARDS RECEIVES FDA APPROVAL FOR SAPIEN 3 WITH ALTERRA PRESTENT FOR TRANSCATHETER PULMONIC VALVE REPLACEMENT
Published: 2021-12-20 (Crawled : 14:30) - biospace.com/
EW | $85.94 -0.59% 0.0% 3.9M
|
Health Technology
|
| O: -1.38%
H: 0.43%
C: -0.34%
fda fda approval approval sap
Bioventus Receives US FDA Clearance for BoneScalpel® Access™
Published: 2021-12-20 (Crawled : 14:30) - biospace.com/
BVS S | $4.48 -1.54% -1.56% 130K
|
|
| O: -1.21%
H: 3.29%
C: -1.76%
bonescalpel fda clearance bone fda clearance
BREXAFEMME® (ibrexafungerp tablets) Added to Major National Formulary, Providing Access for Millions More Commercially Insured Patients
Published: 2021-12-20 (Crawled : 14:30) - biospace.com/
SCYX | $1.44 2.49% 2.43% 130K
|
Health Technology
|
| O: -0.14%
H: 7.52%
C: 6.38%
brexafemme commercialization
PolarityTE Announces Submission of Complete Response to FDA's Clinical Hold Correspondence for SkinTE® Investigational New Drug Application
Published: 2021-12-20 (Crawled : 14:30) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 2.56%
H: 8.75%
C: 8.7%
skinte clinical hold new drug fda application drug skin pons submission response
Novavax Receives Positive European Medicines Agency Recommendation for Conditional Marketing Authorization of its COVID-19 Vaccine
Published: 2021-12-20 (Crawled : 14:30) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 11.76%
H: 2.83%
C: -12.2%
covid-19 europe covid authorization positive vaccine
Avrupa to Acquire Four Exploration Properties in Finland
Published: 2021-12-20 (Crawled : 14:30) - avrupaminerals.com
AVPMF | $0.012 420.0% 18K
|
Miscellaneous
|
| O: -8.0%
H: 0.0%
C: 0.0%
AEM | $63.84 0.58% 0.02% 3.5M
|
Non-Energy Minerals
|
| O: -2.4%
H: 3.15%
C: 2.65%
Enteris BioPharma to Participate in Biotech Showcase Virtual and BIO Partnering at JPM During J.P. Morgan Week 2022
Published: 2021-12-20 (Crawled : 14:30) - biospace.com/
SWKH | $17.52 1.04% 1.03% 7.7K
|
Miscellaneous
|
| O: 0.47%
H: 1.25%
C: 0.31%
biopharma biotech iot
Oral Splicing Modifiers that Systemically Lower Huntington Disease Protein Discovered Through PTC Therapeutics' Innovative Splicing Platform
Published: 2021-12-20 (Crawled : 14:30) - biospace.com/
PTCT | News S | $25.32 2.55% 2.49% 3.9M
|
Health Technology
|
| O: -0.59%
H: 4.81%
C: 3.55%
huntington therapeutics disease platform huntington’s disease
Financial 15 Split Corp. Monthly Dividend Declaration for Class A & Preferred Share
Published: 2021-12-20 (Crawled : 14:30) - globenewswire.com
C | News | $59.14 1.41% 0.07% 13M
|
Finance
|
| O: -1.58%
H: 0.22%
C: -0.55%
CM | $47.57 0.74% 0.0% 3.5M
|
Finance
|
| O: -0.6%
H: 0.11%
C: 0.03%
BMO | News | $92.14 1.24% 0.0% 310K
|
Finance
|
| O: -2.82%
H: 0.16%
C: -0.77%
Dividend 15 Split Corp. II Monthly Dividend Declaration for Class A & Preferred Share
Published: 2021-12-20 (Crawled : 14:30) - globenewswire.com
CIXX | $11.42 0.0% 0
|
Finance
|
| O: -1.59%
H: 0.0%
C: -0.93%
TAC | News | $6.45 0.31% 0.0% 1M
|
Utilities
|
| O: -0.66%
H: 1.04%
C: 0.66%
TRI | $150.22 -0.38% 0.0% 380K
|
Commercial Services
|
| O: -0.98%
H: 1.23%
C: 0.8%
TU | $15.92 0.89% 0.0% 1.8M
|
Communications
|
| O: -0.7%
H: 0.97%
C: 0.92%
TRP | $35.7 1.16% 0.67% 4.8M
|
Industrial Services
|
| O: -1.12%
H: 1.29%
C: 1.09%
RY 1 d | $97.86 0.99% 0.0% 790K
|
Finance
|
| O: -1.59%
H: 0.92%
C: 0.17%
BMO | News | $92.14 1.24% 0.0% 310K
|
Finance
|
| O: -2.82%
H: 0.16%
C: -0.77%
Prime Dividend Corp. Monthly Dividend Declaration for Class A & Preferred Share
Published: 2021-12-20 (Crawled : 14:30) - globenewswire.com
CIXX | $11.42 0.0% 0
|
Finance
|
| O: -1.59%
H: 0.0%
C: -0.93%
SLF 1 d | $51.11 0.89% 0.0% 410K
|
Finance
|
| O: -1.16%
H: 0.47%
C: -0.19%
RY 1 d | $97.86 0.99% 0.0% 790K
|
Finance
|
| O: -1.59%
H: 0.92%
C: 0.17%
MFC 1 d | $23.07 0.61% 0.0% 1.9M
|
Finance
|
| O: -1.54%
H: 0.36%
C: 0.28%
BMO | News | $92.14 1.24% 0.0% 310K
|
Finance
|
| O: -2.82%
H: 0.16%
C: -0.77%
primec
Commerce Split Monthly Dividend Declared for Class I and Class II Preferred Shares
Published: 2021-12-20 (Crawled : 14:30) - globenewswire.com
CM | $47.57 0.74% 0.0% 3.5M
|
Finance
|
| O: -0.6%
H: 0.11%
C: 0.03%
Canadian Life Companies Split Corp. Preferred Dividend Declared
Published: 2021-12-20 (Crawled : 14:30) - globenewswire.com
GWLIF 1 d | $29.16 0.14% 330
|
Finance
|
| O: 1.72%
H: 0.0%
C: -2.88%
SLF 1 d | $51.11 0.89% 0.0% 410K
|
Finance
|
| O: -1.16%
H: 0.47%
C: -0.19%
MFC 1 d | $23.07 0.61% 0.0% 1.9M
|
Finance
|
| O: -1.54%
H: 0.36%
C: 0.28%
Canadian Banc Corp. Monthly Dividend Declaration for Class A & Preferred Share
Published: 2021-12-20 (Crawled : 14:30) - globenewswire.com
RY 1 d | $97.86 0.99% 0.0% 790K
|
Finance
|
| O: -1.59%
H: 0.92%
C: 0.17%
CM | $47.57 0.74% 0.0% 3.5M
|
Finance
|
| O: -0.6%
H: 0.11%
C: 0.03%
BMO | News | $92.14 1.24% 0.0% 310K
|
Finance
|
| O: -2.82%
H: 0.16%
C: -0.77%
Navient adopts short-term shareholder rights plan with 20% trigger
Published: 2021-12-20 (Crawled : 14:30) - globenewswire.com
AVNT | $42.52 0.38% -0.12% 620K
|
Process Industries
|
| O: -2.04%
H: 0.02%
C: -0.56%
NAVI | $16.19 -0.43% -0.43% 1.1M
|
Finance
|
| O: -1.5%
H: 0.67%
C: -4.62%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.